An enhancement of extrachromosomal circular DNA enrichment and amplification to address the extremely low overlap between replicates

dc.contributor.authorBurnham C.M.
dc.contributor.authorKurilung A.
dc.contributor.authorWanchai V.
dc.contributor.authorRegenberg B.
dc.contributor.authorDelgado-Calle J.
dc.contributor.authorBasnakian A.G.
dc.contributor.authorNookaew I.
dc.contributor.correspondenceBurnham C.M.
dc.contributor.otherMahidol University
dc.date.accessioned2026-04-10T18:27:55Z
dc.date.available2026-04-10T18:27:55Z
dc.date.issued2026-04-01
dc.description.abstractExtrachromosomal circular DNA (eccDNA) of chromosomal origin is present in all eukaryotic organisms and tissues that have been tested. Populations of eccDNA exhibit immense diversity and a characteristically low degree of overlap between samples, suggesting low inheritance of eccDNA between cells or a deficiency in the methods by which eccDNA is detected. This study revisits the Circle-Seq approach for enrichment of eccDNA to address these limitations, hypothesizing that experimental procedures significantly contribute to the observed low eccDNA overlap. We optimized the protocol by reducing the time needed to complete the procedure. Linear DNA is digested by increasing Exonuclease V activity. We employed CRISPR-Cas9 for mitochondrial linearization, which proved superior to using restriction enzymes. A key finding is the critical role of random hexamer primer concentration and genomic DNA input in rolling circle amplification (RCA) for generating high-quality long concatemeric tandem copy amplicons from eccDNA, essential for confident de novo eccDNA construction from long-read sequencing data. Lower primer concentrations substantially increased the percentage of concatemer-derived eccDNA and improved the overlap of identified eccDNAs in technical replicates. Applying this revised approach to human myeloma and breast cancer cell lines, as well as xenograft models, demonstrated >50% overlap in detected eccDNA, a substantial improvement over the <1% overlap observed in previous studies. Additionally, the oncogenic signature of eccDNAs can be identified across all replicates. These findings provide guidelines for developing standardized procedures for eccDNA profiling, advancing our understanding of eccDNA biology, and its potential clinical applications.
dc.identifier.citationJournal of Biological Chemistry Vol.302 No.4 (2026)
dc.identifier.doi10.1016/j.jbc.2026.111302
dc.identifier.eissn1083351X
dc.identifier.issn00219258
dc.identifier.pmid41724384
dc.identifier.scopus2-s2.0-105034623274
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116077
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.titleAn enhancement of extrachromosomal circular DNA enrichment and amplification to address the extremely low overlap between replicates
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105034623274&origin=inward
oaire.citation.issue4
oaire.citation.titleJournal of Biological Chemistry
oaire.citation.volume302
oairecerif.author.affiliationKøbenhavns Universitet
oairecerif.author.affiliationUAMS College of Medicine
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationWinthrop P. Rockefeller Cancer Institute

Files

Collections